News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Investor
Amarantus BioSciences, Inc. Effects Capital Restructuring In Anticipation Of National Exchange Listing 5/22/2015
CEL-SCI (CVM) Prices Up To $16 Million Public Offering Of Common Stock And Warrants 5/22/2015
Valeant (VRX) Chief Calls Recent Biotech M&A "Bit of a Bubble" 5/22/2015
NovaBay Pharmaceuticals, Inc. (NBY) Announces $6.86 Million "At Market" Private Placement 5/22/2015
Atrion (ATRI) Declares Quarterly Cash Dividend 5/22/2015
Aldeyra Therapeutics (ALDX) Announces Closing Of Common Stock Offering 5/22/2015
Karolinska Development AB's Annual General Meeting 2015 5/21/2015
Agenus (AGEN) Announces Pricing Of Its Public Offering Of Common Stock 5/21/2015
Dicerna (DRNA) Announces Pricing Of Follow-On Offering Of Common Stock 5/21/2015
Fate Therapeutics (FATE) Announces Pricing Of Public Offering Of Common Stock 5/21/2015
Quintiles Transnational Corp. Announces Closing Of Secondary Public Offering And Repurchase Of Common Stock 5/20/2015
Helix Biopharma (TSX:HBP) Retains The Trout Group As Investor Relations Advisor 5/20/2015
Galapagos (GLPG.BR) Announces Capital Increase 5/20/2015
Portage Biotech Announces Proposed Private Placement 5/20/2015
Valeant (VRX) Announces 2015 Annual Meeting Results 5/20/2015
Momenta (MNTA) Announces Pricing Of Public Offering Of Common Stock 5/20/2015
CohBar Announces Commencement Of Trading On The OTCQX Marketplace 5/20/2015
BioSpace (DHX) Temperature Poll: Will Mylan (MYL) Buy Teva (TEVA), As Predator Becomes Prey? 5/19/2015
Momenta Pharmaceuticals, Inc. (MNTA) Announces Proposed Public Offering Of Common Stock 5/19/2015
Billionaire Doubles Down On Valeant (VRX) 5/19/2015
Pluristem Therapeutics (PSTI) To Conduct Conference At Tel Aviv Stock Exchange To Review Regulatory Progress And Company Strategy 5/19/2015
Fate Therapeutics (FATE) Announces Proposed Public Offering Of Common Stock 5/19/2015
Lucideon (Formerly Known As CERAM) To Host Free Seminar – "Sampling Best Practice For Improved Business Performance" – 12 June 2015 5/19/2015
Citi Appointed Depositary Bank For Adaptimmune’s ADR Programme 5/19/2015
Dicerna (DRNA) Announces Follow-On Public Offering Of Common Stock 5/19/2015
NeuroVive: NeuroVive Announces Prospectus Regarding Admission To Trading Of New Shares 5/19/2015
Easton Pharmaceuticals (OP: EAPH) Letter To Shareholders 5/19/2015
Pfizer (PFE) Invites Public To View And Listen To Webcast Of June 2 Conference Call With Analysts To Review Oncology Business And ASCO Data Presentations 5/19/2015
GW Pharma (GWPH) Announces Full Exercise Of Underwriters' Option To Purchase Additional American Depositary Shares 5/18/2015
Bacterin International, Inc. Sets Annual Meeting And Record Dates 5/18/2015
AbbVie (ABBV) Extends Exchange Offer To Acquire Pharmacyclics (PCYC) 5/18/2015
Galapagos (GLPG.BR) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 5/18/2015
Akorn, Inc. (AKN) Receives NASDAQ Delinquency Notice 5/18/2015
PTC Therapeutics (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 5/18/2015
Baxter International (BAX) And Baxalta Highlight Business Strategies At Investor Conferences 5/18/2015
BioInvent (BOVNF): BioInvent’s Rights Issue Oversubscribed 5/18/2015
Atossa Genetics, Inc. (ATOS) To Host Conference Call Today, Monday, May 18, 2015 At 4:30pm Eastern Time To Provide Company Update 5/18/2015
Telesta Therapeutics Publishes Its Nine Month Financial Results To March 31, 2015 And Provides Corporate Updates 5/15/2015
INC Research, Inc. (INCR) Completes Secondary Offering, Stock Repurchase And Debt Refinancing; Updates 2015 Business Outlook 5/15/2015
Amgen (AMGN) Announces Voting Results Of Annual Meeting Of Stockholders 5/15/2015
Galectin Therapeutics To Webcast Corporate Update Following Annual Meeting Of Stockholders 5/15/2015
CymaBay Therapeutics To Ring The Nasdaq Stock Market Closing Bell 5/15/2015
Tekla Life Sciences Investors Declared Stock Distribution 5/15/2015
Cystic Fibrosis Biotech Nivalis Therapeutics Files for $60 Million IPO 5/14/2015
Hikma Pharmaceuticals (HIK.L) Release: AGM Trading Update 5/14/2015
Cipher Pharma (DND.TO) Reports Voting Results From Annual And Special Meeting Of Shareholders 5/14/2015
Dow Announces Results From Annual Stockholder Meeting 5/14/2015
Agilent Technologies Inc. (A) To Host Webcast Of Analyst And Investor Meeting 5/14/2015
Quintiles (Q) Announces Pricing Of Secondary Public Offering 5/14/2015
Spectrum Pharmaceuticals, Inc. (SPPI) Commits To Review Shareholder Proposal 5/14/2015
Emergent BioSolutions (EBS) To Hold Annual Meeting Of Stockholders Thursday May 21, 2015 At 9:00 AM Eastern; Webcast Will Be Available 5/14/2015
Dow Chemical  (DOW) Announces Results From Annual Stockholder Meeting 5/14/2015
A Battle is Brewing Between Keryx (KERX)'s Largest Backer and Short Investors 5/13/2015
aTyr Pharma Announces Closing Of Initial Public Offering 5/13/2015
Neurocrine Biosciences, Inc. (NBIX) To Host Analyst And Investor Day In New York City On May 21, 2015 5/13/2015
Valeant (VRX) To Webcast 2015 Annual Meeting Of Shareholders 5/13/2015
TiGenix: Convening Notice To The Extraordinary Shareholders' Meeting To Be Held On 2 June 2015 5/13/2015
Report From The 2015 Annual General Meeting In Aerocrine 5/13/2015
Bristol-Myers Squibb (BMY) Announces The Pricing Terms Of Its Cash Tender Offer For Up To $500 Million Aggregate Principal Amount Of Its Outstanding Debt Securities 5/13/2015
Onxeo: Publication Of A Letter To Shareholders – May 2015 5/13/2015
Relypsa (RLYP) Announces New Employment Inducement Grants 5/12/2015
Eli Lilly (LLY) Announces Cash Tender Offer For Up To $1.6 Billion Aggregate Principal Amount Of Its Outstanding Debt Securities And The Redemption Of Its 6.57% Notes Due 2016 5/12/2015
LEERINK Partners Expands Investment Banking Franchise 5/12/2015
Bristol-Myers Squibb (BMY) Announces The Early Results Of Its Cash Tender Offer For Up To $400 Million Aggregate Principal Amount Of Its Outstanding Debt Securities; Increases The Maximum Amount Of The Tender Offer 5/12/2015
Skyepharma PLC (SKYEF) AGM Trading Update 5/12/2015
Moberg Pharma AB (Formerly known as Moberg Derma): Bulletin from Moberg Pharma’s Annual General Meeting 2014 5/12/2015
MYOS (MYOS) To Host Conference Call To Discuss Quarterly Update And Management Highlights 5/12/2015
Antares Pharma, Inc. (ATRS) Announces Closing Of Public Offering Of Common Stock 5/12/2015
BioDelivery Sciences International (BDSI) Provides Corporate Update and Reports First Quarter 2015 Financial Results 5/11/2015
BioScrip (BIOS) Announces Proposal To Commence Exchange Offer 5/11/2015
GenSpera Provides Corporate Update 5/11/2015
M-Pharmaceutical - Shareholder Update 5/11/2015
Acasti Pharma Receives Extension to Regain Compliance With NASDAQ Minimum Bid Price Rule 5/11/2015
Aegerion (AEGR) Grants Stock Options Under Inducement Program 5/11/2015
HEALTHSOUTH Declares Dividend On Common Stock 5/8/2015
China Cord Blood Corporation Receives Notice Of Transactions Regarding Its 7% Senior Convertible Notes Due 2017 Held By Cordlife And Magnum And Its Ordinary Shares Held By CordLife Ltd. 5/8/2015
Celator Pharmaceuticals, Inc. Announces Business Update And First Quarter 2015 Financial Results 5/8/2015
Aldeyra Therapeutics (ALDX) Announces Pricing Of Follow-On Public Offering Of Common Stock 5/8/2015
Aceto Corporation Board Of Directors Declares Quarterly Cash Dividend 5/8/2015
Provectus Biopharmaceuticals Inc. Updates Market On Business Developments 5/8/2015
Manhattan Scientifics, Inc. Issues Letter From The New President Of Its Senior Scientific Subsidiary 5/8/2015
Golden Meditech Proposes To Purchase CCBC Convertible Notes Held By Magnum And CCBC Convertible Notes And CCBC Shares Held By CGL 5/8/2015
Bulletin From Annual General Meeting In Recipharm AB 5/8/2015
Two Under-the-Radar Updates Pfizer (PFE) Investors Need to Know About 5/7/2015
GENFIT (ALGFT): Ordinary General Shareholders’ Meeting Of June 3, 2015 – Availability Of Preparatory Documents 5/7/2015
aTyr Pharma Announces Pricing Of Initial Public Offering 5/7/2015
IMRIS Announces Postponement Of Its Annual Meeting Of Shareholders And Release Of First Quarter 2015 Financial Results And Conference Call 5/7/2015
Kythera (KYTH) Grants Stock Options Under Inducement Program 5/7/2015
Asterias Biotherapeutics To Host Investor Meeting To Review Clinical Development Strategy For AST-OPC1 In Spinal Cord Injury 5/7/2015
Affimed Therapeutics AG (AFMD) Announces Pricing Of Public Offering Of Common Stock 5/7/2015
GENFIT (ALGFT) Announces Its Turnover And Cash Situation As Of March 31, 2015 5/7/2015
Zivo Bioscience, Inc. Announces Increase In Credit Facility From Primary Lender And Notice Of Convertible Debt Conversion 5/7/2015
Stevia First Corp. Announces $1.5 Million Private Placement With Institutional Investors 5/7/2015
Horizon Pharma (HZNP) Announces Results Of Tender Offer 5/7/2015
Edwards Lifesciences (EW) To Webcast Annual Meeting Of Stockholders 5/7/2015
INC Research, Inc. (INCR) Announces Pricing Of Secondary Offering 5/7/2015
IDEXX Laboratories, Inc. (IDXX) Announces Two-For-One Stock Split And Increase In Share Repurchase Program 5/6/2015
GW Pharmaceuticals plc Announces The Closing Of U.S. Public Offering Of American Depositary Shares (Adss) Raising Approximately $179.2 Million On The NASDAQ Global Market 5/6/2015
Antares Pharma, Inc. (ATRS) Announces Pricing Of Public Offering Of Common Stock 5/6/2015
Paratek Pharmaceuticals, Inc. Announces Closing Of Common Stock Offering 5/6/2015
Advaxis, Inc. Announces Closing Public Offering Of Common Stock With Gross Proceeds Totaling $53.2 Million 5/6/2015
Galapagos (GLPG.BR) Announces Launch Of Proposed Global Offering 5/6/2015
Galapagos (GLPG.BR) Listed 10 Years On Euronext Amsterdam And Brussels 5/6/2015
Medivir AB (MVRBF)’s Board Of Directors Has Resolved To Repurchase Own Shares 5/6/2015
Thermo Fisher Scientific (TMO) To Host Analyst Meeting 5/6/2015
CEL-SCI (CVM) Announces Proposed Public Offering Of Common Stock 5/6/2015
pSivida (PSDV)'s Drug Delivery Technology Business Model Draws Comparison to Regeneron (REGN) Blockbuster Success 5/6/2015
Blueprint Medicines (BPMC) Announces Closing of Initial Public Offering 5/5/2015
SV Bank Exec: New Companies Are Booming, As “Frothy” Market Looks to Novel Science 5/5/2015
Bio-Techne (TECH) Declares Dividend 5/5/2015
Aldeyra Therapeutics (ALDX) Launches Proposed Follow-On Public Offering Of Common Stock 5/5/2015
Cytori Therapeutics, Inc. (CYTX) Prices Registered Direct Offering Providing For Up To $25 Million In Equity Financing 5/5/2015
Baxter International (BAX) Declares Quarterly Dividend 5/5/2015
Cardio3 Biosciences Announces Results Of Annual Shareholder Assembly 2015 And Confirmation Of Name Change To Celyad 5/5/2015
Inovio Pharmaceuticals (INO) Closes $87.4 Million Underwritten Financing 5/5/2015
Five Things to Take Away From Vertex (VRTX)'s Q1 5/4/2015
Stressed GlaxoSmithKline (GSK) May Put $6.1 Billion Payout on Hold As New Chairman Arrives 5/4/2015
China Cord Blood Corporation Receives Notice Of A Transaction Regarding Its 7% Senior Convertible Notes Due 2017 Held By KKR 5/4/2015
EcoScience Corporation Significantly Reduces Number Of Outstanding Common Stock 5/4/2015
Burcon Nutrascience Corp. (BU) Announces Completion Of Over-Subscribed Rights Offering 5/4/2015
Tikcro Technologies Files Annual Report On Form 20-F For The Year Ended December 31, 2014 5/4/2015
Generex Biotechnology Corporation (GNBT) Announces Intention To Dividend A Portion Of Anticipated SMFI Securities To Its Stockholders Upon A Reverse Stock Split 5/4/2015
Webcast Alert: Heska Corporation (HSKA)'s Annual Meeting Of Stockholders Webcast 5/4/2015
Affimed Therapeutics AG (AFMD) Announces Proposed Public Offering Of Common Stock 5/4/2015
Macrocure (MCUR) Files Annual Report On Form 20-F For The Year Ended December 31, 2014 5/4/2015
Kite Pharma (KITE) CEO Avoids Big Tax Bite By Exercising Options Before IPO 5/4/2015
TetraLogic Pharmaceuticals (TLOG) Announces Pricing Of $25 Million Public Offering 5/1/2015
Lion Biotechnologies, Inc. Announces Pricing Of Secondary Offering Of Shares By Selling Stockholders 5/1/2015
TetraLogic Pharmaceuticals (TLOG) Announces Public Offering Of Common Stock 5/1/2015
BioAmber Inc. Announces Public Offering Of Common Stock 5/1/2015
WuXi PharmaTech Co., Ltd. Announces Receipt Of Proposal 5/1/2015
Northwest Biotherapeutics (NWBO) Rakes In $28.5 Million 5/1/2015
Quintiles (Q) Announces Proposed Offering Of $800 Million Of Senior Notes 5/1/2015
Sarepta (SRPT) Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 5/1/2015
NephroGenex (NRX) Announces Proposed Offering Of Common Stock 5/1/2015
Juniper Pharmaceuticals Reschedules Annual General Meeting 4/30/2015
Pfenex (PFNX) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/30/2015
OncoGenex Pharmaceuticals Inc. (OGXI) Announces Share Purchase Agreement With Lincoln Park Capital Fund, LLC 4/30/2015
Lipocine Inc. (LPCN) Prices $30.2 Million Public Offering Of Common Stock 4/30/2015
Lipocine Inc. (LPCN) Announces Closing Of $34.8 Million Common Stock Offering 4/30/2015
Inovio Pharmaceuticals (INO) Announces Public Offering Of Common Stock 4/30/2015
StemCells (STEM) Announces Closing Of $25 Million Public Offering 4/30/2015
Advaxis, Inc. Announces Proposed Public Offering Of Common Stock 4/30/2015
Inovio Pharmaceuticals (INO) Announces Pricing Of Public Offering Of Common Stock 4/30/2015
Paratek Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of 2,860,000 Shares Of Common Stock 4/30/2015
Advaxis, Inc. Prices $53 Million Public Offering Of Common Stock 4/30/2015
DS Healthcare Group Regains Compliance With Nasdaq Listing Requirements 4/30/2015
Neptune Technologies & Bioressources Inc. Provides Business Update 4/30/2015
Invitation - Presentation Of Sobi's First Quarter 2015 4/30/2015
Bristol-Myers Squibb (BMY) Prices €1.15 Billion Of Senior Notes 4/30/2015
WuXi PharmaTech Co., Ltd. Receives $3.2 Billion Privatization Offer 4/30/2015
Helix Biopharma (TSX:HBP) Closes Additional Private Placement Financing 4/30/2015
Teva (TEVA) Sends Letter To Mylan (MYL) Board 4/30/2015
Sinovac Biotech Ltd. (SVA) Files 2014 Annual Report On Form 20-F 4/29/2015
GW Pharma (GWPH) Raises $179.2 Million NASDAQ Cash 4/29/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Extension To Regain Compliance With Nasdaq's Minimum Bid Price Rule 4/29/2015
Novogen Limited (NVGN) Completes The Private Placement Of Equity 4/29/2015
NeuroDerm Ltd. (NDRM) Files Annual Report On Form 20-F For The Year Ended December 31, 2014 4/29/2015
ProQR Therapeutics B.V. (PRQR) Announces Annual Shareholder Meeting 4/29/2015
Sobi's Board Of Directors Postpones Annual General Meeting Of Shareholders 4/29/2015
Simulations Plus (SLP) Announces Quarterly Cash Dividend Of $0.05 Per Share 4/29/2015
Looking At Biogen (BIIB) Through Warren Buffett's Eyes 4/29/2015
Basilea Pharmaceutica (BSLN.SW) Shareholders Approve All Resolutions Proposed By The Board Of Directors At The Ordinary General Meeting Of Shareholders 4/29/2015
Quintiles (Q) Announces Proposed Refinancing Of Existing Indebtedness 4/29/2015
Golden Meditech Proposes Open Offer To Eligible Shareholders To Subscribe One Offer Share For Every Two Shares Held And To Acquire Outstanding Ordinary Shares Of China Cord Blood Corporation 4/29/2015
GW Pharmaceuticals (GWPH) Announces Proposed Public Offering Of ADSs 4/28/2015
Paratek Pharmaceuticals, Inc. Announces Proposed Public Offering Of Common Stock 4/28/2015
22nd Century Group, Inc. Provides Highlights From Annual Shareholder Meeting 4/28/2015
China Cord Blood Corporation Receives $512 Million Take-Private Offer 4/28/2015
Novogen Limited (NVGN) Regains Full Compliance With NASDAQ Listing Rule 4/28/2015
Syngenta AG (SYT) Annual General Meeting 4/28/2015
ERYtech Pharma Receives The EnterNext Tech 40 Label 4/28/2015
Horizon Pharma (HZNP) Announces Pricing Of Private Offering Of Senior Notes 4/28/2015
Precise Biometrics AB: Resolutions At Precise Biometrics´ Annual General Meeting 2015 4/28/2015
22nd Century Group, Inc. Provides Highlights From Annual Shareholder Meeting 4/28/2015
Bristol-Myers Squibb (BMY) Announces Cash Tender Offer For Up To $400 Million Aggregate Principal Amount Of Its Outstanding Debt Securities 4/28/2015
Buy Vertex (VRTX) Now for $45B Or Risk It All, Analyst Tells Gilead (GILD) 4/27/2015
Pfenex (PFNX) Announces Pricing Of Follow-On Offering 4/27/2015
CytoSorbents, Inc. Issues Letter To Shareholders 4/27/2015
Telesta Therapeutics Provides Key Corporate Updates 4/27/2015
Akorn, Inc. (AKN) To Make Additional Financial Restatements 4/27/2015
INC Research, Inc. (INCR) Files Registration Statement For Secondary Offering 4/27/2015
Coronado Biosciences (CNDO) Changes Its Name To Fortress Biotech 4/27/2015
Sartorius Stedim Biotech Release: New Webinar On Faster cGMP Manufacturing Scale-up Of Biotherapeutics 4/27/2015
Acucela Provides Important Company Updates 4/27/2015
AxoGen, Inc. (AXGN) Announces 2015 Annual Shareholders’ Meeting 4/27/2015
Lipocine Inc. (LPCN) Announces Proposed Public Offering Of Common Stock 4/24/2015
StemCells (STEM) Announces Proposed Public Offering Of Common Stock And Warrants 4/24/2015
Lipocine Inc. (LPCN) Prices $30.2 Million Public Offering Of Common Stock 4/24/2015
Innocoll, Inc. (INNL) Announces Pricing Of Follow-On Offering 4/24/2015
StemCells (STEM) Announces Pricing Of Public Offering To Raise $25 Million 4/24/2015
Athersys (ATHX) To Host Shareholder Conference Call 4/24/2015
Nordic Nanovector – Share Capital Increase Registered 4/24/2015
BioTie Therapies Corp. Release: Notification According To Chapter 9, Section 5 Of The Finnish Securities Markets Act 4/24/2015
RestorGenex Issues Annual Letter To Stockholders 4/23/2015
SCYNEXIS, Inc. (SCYX) Announces Pricing Of Public Offering Of Common Stock 4/23/2015
Celgene (CELG) To Webcast At Upcoming Investor Conferences And Medical Meetings In May 4/23/2015
Change In BioTie Therapies Corp.' Financial Calendar 2015 4/23/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 4/23/2015
Akebia Therapeutics, Inc. (AKBA) Announces Closing Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/23/2015



//-->